日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Growth Hormone Pathway as a Prognostic and Therapeutic Biomarker in Patients With Unresectable Hepatocellular Carcinoma Treated With Radiation Therapy

生长激素通路作为不可切除肝细胞癌放射治疗患者的预后和治疗生物标志物

Eid, Joe R; Kaseb, Safa; Xiao, Lianchun; Sun, Ryan; Kannan, Mahesh Kumar; Hassan, Manal; Rashid, Asif; Cao, Hop S Tran; Amin, Hesham M; Koay, Eugene J

Evaluating the role of preoperative serum insulin-like growth factor 1 as a predictor of survival and recurrence for patients with resectable hepatocellular carcinoma

评估术前血清胰岛素样生长因子1作为可切除肝细胞癌患者生存和复发预测指标的作用

Eid, Joe; Haddad, Antony; Hassan, Manal; Amin, Hesham M; Newhook, Timothy E; Chun, Yun Shin; Tzeng, Ching-Wei D; Vauthey, Jean-Nicolas; Tran Cao, Hop S; Kaseb, Ahmed O

Circulating Fibroblast Growth Factor 21 (FGF21) as a Prognostic and Diagnostic Biomarker in Hepatocellular Carcinoma

循环成纤维细胞生长因子21 (FGF21) 作为肝细胞癌的预后和诊断生物标志物

Eid, Joe R; Yalciner, Merih; Xiao, Lianchun; Sun, Ryan; Kannan, Mahesh Kumar; Hassan, Manal; Rashid, Asif; Chamseddine, Shadi; Tran Cao, Hop S; Amin, Hesham M; Kaseb, Ahmed O

Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma.

可切除肝细胞癌患者接受新辅助纳武利尤单抗或纳武利尤单抗联合伊匹木单抗治疗的组织和影像生物标志物反应

LaPelusa Michael, Chamseddine Shadi, Tran Cao Hop Sanderson, Xiao Lianchun, Hasanov Elshad, Bhosale Priya, Amin Hesham M, Mohamed Yehia I, Gok Yavuz Betul, Sakr Yara, Xu Li, Hu Ian, Lee Sunyoung S, Sakamuri Divya, Jindal Sonali, Nguyen Van, Curran Michael A, Sun Ryan, Rashid Asif, Duda Dan Gabriel, Sharma Padmanee, Qayyum Aliya, Kaseb Ahmed Omar

Genome-wide association study identifies high-impact susceptibility loci for HCC in North America

全基因组关联研究揭示北美肝细胞癌高影响易感基因位点

Hassan, Manal M; Li, Donghui; Han, Younghun; Byun, Jinyoung; Hatia, Rikita I; Long, Erping; Choi, Jiyeon; Kelley, Robin Kate; Cleary, Sean P; Lok, Anna S; Bracci, Paige; Permuth, Jennifer B; Bucur, Roxana; Yuan, Jian-Min; Singal, Amit G; Jalal, Prasun K; Ghobrial, R Mark; Santella, Regina M; Kono, Yuko; Shah, Dimpy P; Nguyen, Mindie H; Liu, Geoffrey; Parikh, Neehar D; Kim, Richard; Wu, Hui-Chen; El-Serag, Hashem; Chang, Ping; Li, Yanan; Chun, Yun Shin; Lee, Sunyoung S; Gu, Jian; Hawk, Ernest; Sun, Ryan; Huff, Chad; Rashid, Asif; Amin, Hesham M; Beretta, Laura; Wolff, Robert A; Antwi, Samuel O; Patt, Yehuda; Hwang, Lu-Yu; Klein, Alison P; Zhang, Karen; Schmidt, Mikayla A; White, Donna L; Goss, John A; Khaderi, Saira A; Marrero, Jorge A; Cigarroa, Francisco G; Shah, Pankil K; Kaseb, Ahmed O; Roberts, Lewis R; Amos, Christopher I

Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma

血浆生长激素作为晚期肝细胞癌患者接受度伐利尤单抗和曲美利尤单抗治疗的预后生物标志物

Chamseddine, Shadi; LaPelusa, Michael; Xiao, Lianchun; Mohamed, Yehia I; Lee, Sunyoung S; Hu, Zishuo Ian; Hatia, Rikita I; Hassan, Manal; Yao, James C; Duda, Dan G; Datar, Saumil; Amin, Hesham M; Kaseb, Ahmed O

Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma

循环半乳糖凝集素-3:肝细胞癌的预后生物标志物

Chamseddine, Shadi; Yavuz, Betul Gok; Mohamed, Yehia I; Lee, Sunyoung S; Yao, James C; Hu, Zishuo Ian; LaPelusa, Michael; Xiao, Lianchun; Sun, Ryan; Morris, Jeffrey S; Hatia, Rikita I; Hassan, Manal; Duda, Dan G; Diab, Maria; Mohamed, Amr; Nassar, Ahmed; Amin, Hesham M; Kaseb, Ahmed Omar

Severe febrile neutropenia and pancytopenia in a patient with advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab: a case report

一例接受阿特珠单抗和贝伐珠单抗治疗的晚期肝细胞癌患者出现严重发热性中性粒细胞减少症和全血细胞减少症的病例报告

Chamseddine, Shadi; LaPelusa, Michael; Carter, Kristen; Nguyen, Van; Mohamed, Yehia I; Sakr, Yara; Rojas-Hernandez, Cristhiam M; Hatia, Rikita I; Hassan, Manal; Goss, John A; Elsayes, Khaled M; Rashid, Asif; Sun, Ryan; Tran Cao, Hop Sanderson; Amin, Hesham M; Kaseb, Ahmed O

Circulating tumor DNA (ctDNA) as a biomarker of response to therapy in advanced Hepatocellular carcinoma treated with Nivolumab

循环肿瘤DNA(ctDNA)作为接受纳武利尤单抗治疗的晚期肝细胞癌患者疗效的生物标志物

Mohamed, Yehia I; Lee, Sunyoung S; Demir, Tarik; Chamseddine, Shadi; Hu, Zishuo Ian; Xiao, Lianchun; Elsayes, Khaled; Morris, Jeffrey S; Wolff, Robert A; Hiatia, Rikita; Qayyum, Aliya; Rashid, Asif; Duda, Dan G; Yao, James C; LaPelusa, Michael; Koay, Eugene J; Mahvash, Armeen; Al Azzam, Ahmed; Dumbrava, Ecaterina E; Hassan, Manal; Amin, Hesham M; Kaseb, Ahmed Omar

Correction: Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK(+) T-cell lymphoma

更正:同时抑制IGF-IR和ALK是根除NPM-ALK(+) T细胞淋巴瘤的有效策略

George, Bhawana; George, Suraj Konnath; Shi, Wenyu; Haque, Abedul; Shi, Ping; Eskandari, Ghazaleh; Axelson, Magnus; Larsson, Olle; Kaseb, Ahmed O; Amin, Hesham M